FDA Investigator Valerie Jgrecek Trinh
Valerie Jgrecek Trinh has conducted inspections on 335 sites in 1 countries as of 17 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
335
Last Inspection Date:
17 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Valerie Jgrecek Trinh:
Abraham M Maekele,
Adaliz Santaliz Cruz,
Albert A Salvador,
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Amanda B Vega,
Amber D Brodas,
Amy A Johnson,
Amy Constantine,
Amy H Ruble,
Amy Kim,
Amy Wyan Mai,
Ana Delp Cintron,
Ana P Barido,
Andrea H Norwood,
Andrew F Cohen,
Andrew J Mcguffin,
Angela E Glenn,
Angela Jourdain,
Arduino Frankovic,
Arthur S Williams, Jr,
Ashley A Mutawakkil,
Ashley A Segura,
Ashley B Jelonek,
Barbara Paul,
Barbara T Carmichael,
Bonita S Chester,
Brandy D Brown,
Brant M Schroeder,
Burnell M Henry,
Carl E Lovrich,
Carla A Norris,
Chad R Burger,
Charisse K Green,
Cheryl A Clausen,
Christopher J Adams,
Clara E Santiago,
Cody D Rickman,
Colleen M Aspinwall,
Courtney A Gilbert,
Courtney A Hunt,
Dave M Deroche,
Demitria J Xiradakis,
Devaughn Edwards,
Diane Hall,
Dianiris C Ayala,
Dionne D Arline,
Dipesh K Shah,
Donald J Mee,
Donald J Ullstrom,
Doretha M Wilson,
Dorothy W Lee,
Douglas G Ng,
Dr. Barbara D Paul, PhD,
Dr. Gang Wang, PhD,
Dwayne E Dollins,
Eric M Padgett,
Ethan P Stegman,
Evelyn Taha,
Fabian Nchaparro Rodriguez,
Fatima Bassa,
Frank Verni,
Gary E Coleman, Jr, REHS,
Gayle J Gehrman,
Gene D Arcy,
George M Ibrahim,
German Rivera,
Glenn S Quintanilla,
Gloria E Parra,
Gregson A Joseph,
Harry R Bringger, Jr,
Haydee B Romero,
Helen B Ricalde,
Helen R Bester,
Holly M Scott,
Iram R Hassan, PhD,
Irina Gaberman,
Ivan E Reyes,
Ivy Z Bevill,
Jacqueline Mdiaz Albertini,
Jana L Caylor,
Jane C Chen,
Janet B Gray,
Jason D Abel,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer Macmillan,
John E Aghadia,
Jolanna A Norton,
Jose R Rodriguez,
Joseph A Famiglietti,
Joseph O Sullivan,
Joshua J Silvestri,
Joy P Matthias,
Joyce A Williams,
Juanelma H Palmer,
Juanita P Versace,
Judy Ellen Ciaraldi,
Judy Keihl,
Julie D Bringger,
Justin A Boyd,
Karen M Cruz Arenas,
Karen M Rodriguez,
Kathleen D Culver,
Kellie Leveille,
Kenneth L Smalls,
Kent C Hermann,
Kerun Hardeo,
Kevin A Gonzalez,
Kimberley A Gordon,
Kimberley A Ricketts,
Kip J Hanks,
L Gnnmassimia Massimilla, PharmD,
Laiza V Garcia,
Laura E Garcia,
Laura M Howard,
Laura Schankweiler,
LCDR Randall L Morris,
Leena Thomas,
Leo J Lagrotte,
Leon L Crawley,
Leroy Terrelonge,
Linda K Matheny,
Linda M Sacco,
Lindsay R Hatch,
Lindsay R Mundy,
Lisa A Warner,
Lisa Mathew,
LT Daveta L Bailey,
LTJG Matthew R Palo,
Lura D Baquero,
Lura D Kelly,
Madelyn Renteria,
Marianna Sala Rhatigan,
Marion Michaelis,
Marla A Cassidy,
Matthew B Thomaston,
Megan R Anderson,
Melinda B Lewis,
Mercy O Quagraine,
Meredith P Soehl, Investigator,
Michael I Gorman,
Michael R Dominick,
Michelle D Haamid,
Mizanne E Lewis,
Mohammad Heidaran, PhD,
Nicholas M Smith,
Nisha C Patel,
Nydia E Colon,
Omayra Nrodriguez Ruiz,
Ormond,
Patty P Kaewussdangkul,
Paul L Figarole, Jr,
Peter Abel,
Peter M Trunk,
Randy L Clarida,
Raymond A Lyn, Jr,
Richard J Bashay,
Richard K Vogel,
Rita F Monfort,
Robert C Steyert,
Robert W Mcdowell Jr,
Ronnie E Jackson,
Rosia E Nesbitt,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Samuel Eskenazi,
Sandra D Thompson,
Sarah Forney,
Sergio E Delgado,
Shavon L Square,
Sherbet L Samuels,
Shreya Shah,
Shusheen A Alexander,
Simone E Pitts,
Sonia M Monges,
Stacey F Rivette,
Stanley Noneze,
Steven J Libal,
Susan M Corrales,
Susan M Jackson,
Susan M Turcovski,
Suzanne M Healy,
Taylor G Barker,
Thai D Truong,
Thomas P Hansen,
Traci M Armand,
Valerie A Potopsingh,
Verdell Nelson,
Victoria V Bot,
Xiaokuang Lai, PhD,
Yong Hu,
Yvonne M Santiago
Valerie Jgrecek Trinh's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more